Cannabis adulterated with synthetic cannabinoid receptor agonist MDMB-4en-PINACA
Beginning in Spring 2020, several drug monitoring services detected the synthetic cannabinoid receptor agonist MDMB-4en-PINACA in adulterated low-THC cannabis products. 1,142 samples sold as cannabis in herbal, resin, and e-liquid form were analyzed and 270 were found to contain MDMB-4en-PINACA. All cannabis samples contained low THC except the e-liquids which contained no phytocannabinoids. The authors concluded that since cannabis consumers are not the usual target for drug checking services, harm reduction interventions and services could be reconfigured to include them. Read the full study here.